Chilean Gastric Cancer Task Force: A Study Protocol to Obtain a Clinical and Molecular Classification of a Cohort of Gastric Cancer Patients

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

Eyheramendy S, Martinez F, Manevy F, Vial C, Repetto G . Genetic structure characterization of Chileans reflects historical immigration patterns. Nat Commun. 2015; 6:6472. PMC: 4382693. DOI: 10.1038/ncomms7472. View

Maring J, van Kuilenburg A, Haasjes J, Piersma H, Groen H, Uges D . Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene. Br J Cancer. 2002; 86(7):1028-33. PMC: 2364178. DOI: 10.1038/sj.bjc.6600208. View

Longley D, Harkin D, Johnston P . 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003; 3(5):330-8. DOI: 10.1038/nrc1074. View

Saavedra K, Valbuena J, Olivares W, Marchant M, Rodriguez A, Torres-Estay V . Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer. PLoS One. 2015; 10(5):e0125834. PMC: 4425545. DOI: 10.1371/journal.pone.0125834. View

Cunningham D, Allum W, Stenning S, Thompson J, van de Velde C, Nicolson M . Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355(1):11-20. DOI: 10.1056/NEJMoa055531. View

Corvalan A, Koriyama C, Akiba S, Eizuru Y, Backhouse C, Palma M . Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile. Int J Cancer. 2001; 94(4):527-30. DOI: 10.1002/ijc.1510. View

Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E . Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009; 125(3):666-73. DOI: 10.1002/ijc.24290. View

Apicella M, Corso S, Giordano S . Targeted therapies for gastric cancer: failures and hopes from clinical trials. Oncotarget. 2017; 8(34):57654-57669. PMC: 5593674. DOI: 10.18632/oncotarget.14825. View

10.

Tan I, Ivanova T, Lim K, Ong C, Deng N, Lee J . Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology. 2011; 141(2):476-85, 485.e1-11. PMC: 3152688. DOI: 10.1053/j.gastro.2011.04.042. View

11.

Heise K, Bertran E, Andia M, Ferreccio C . Incidence and survival of stomach cancer in a high-risk population of Chile. World J Gastroenterol. 2009; 15(15):1854-62. PMC: 2670413. DOI: 10.3748/wjg.15.1854. View

12.

Cristescu R, Lee J, Nebozhyn M, Kim K, Ting J, Wong S . Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015; 21(5):449-56. DOI: 10.1038/nm.3850. View

13.

Asaka M, Kato M, Sakamoto N . Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol. 2013; 49(1):1-8. PMC: 3895201. DOI: 10.1007/s00535-013-0897-8. View

14.

Carrasco G, Diaz J, Valbuena J, Ibanez P, Rodriguez P, Araya G . Overexpression of p73 as a tissue marker for high-risk gastritis. Clin Cancer Res. 2010; 16(12):3253-9. DOI: 10.1158/1078-0432.CCR-09-2491. View

15.

Torre L, Siegel R, Ward E, Jemal A . Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev. 2015; 25(1):16-27. DOI: 10.1158/1055-9965.EPI-15-0578. View

16.

Garrido M, Fonseca P, Vieitez J, Frunza M, Lacave A . Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer. Expert Rev Anticancer Ther. 2014; 14(8):887-900. DOI: 10.1586/14737140.2014.915194. View

17.

LAUREN P . THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965; 64:31-49. DOI: 10.1111/apm.1965.64.1.31. View

18.

Kelly C, Janjigian Y . The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond. J Gastrointest Oncol. 2016; 7(5):750-762. PMC: 5056254. DOI: 10.21037/jgo.2016.06.10. View

19.

Camargo M, Murphy G, Koriyama C, Pfeiffer R, Kim W, Herrera-Goepfert R . Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br J Cancer. 2011; 105(1):38-43. PMC: 3137422. DOI: 10.1038/bjc.2011.215. View

20.

van Kuilenburg A, Meinsma R, Zoetekouw L, van Gennip A . Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation. Int J Cancer. 2002; 101(3):253-8. DOI: 10.1002/ijc.10599. View